Regina LaBelle is a professor and the director of the Addiction and Public Policy Initiative at the Georgetown University Law Center's O'Neill Institute for National and Global Health Law.
11 Facts About Regina LaBelle
Regina LaBelle was the acting director of the White House Office of National Drug Control Policy from January 20,2021 to November 5,2021, and the only woman to ever lead this office.
Regina LaBelle was named deputy director and served as acting director by President Joe Biden on the first day of his presidency.
In 2009, Regina LaBelle was appointed to a senior policy advisor to the Director of ONDCP, where she served until January 2017.
When President Obama left office in 2017, Regina LaBelle began a career in academia.
Regina LaBelle served as a visiting fellow at the Duke Margolis Center for Health Policy.
In 2018, Regina LaBelle founded the Addiction and Public Policy Initiative at The O'Neill Institute for National and Global Health Law at Georgetown University Law Center.
Regina LaBelle conceptualized and launched the first of its kind Master of Science in Addiction Policy and Practice program at Georgetown University Graduate School of Arts and Sciences in 2018.
In 2021, Regina LaBelle served on the Biden-Harris Administration's transition team and was appointed by the Administration as Deputy Director of ONDCP.
Regina LaBelle served as Acting Director of ONDCP, the first and only woman to serve in this role.
Regina LaBelle founded the first ever translational science branch at ONDCP, which incorporated research into public policy to ensure that drug policies reflect the latest scientific evidence.